Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for sibeprenlimab, an investigational…
Empowering Patients Through Collaboration: Astellas’ Commitment to Pompe Disease Awareness This article shares real patient stories to raise awareness about Pompe disease. Individual experiences may differ. This content is for…
Running from Friday through June 3 at McCormick Place Convention Center, the 2025 ASCO Annual Meeting promises to unveil pivotal data from a wide range of clinical trials. Experts suggest…
Health Canada has reaffirmed its commitment to safeguarding the country’s drug supply, stating it is “taking all necessary action” to ensure Canadians have continued access to essential prescription medications. This…
Dr. Mark Stetter Joins Zoetis Board of DirectorsDean of the University of California, Davis School of Veterinary Medicine brings extensive and valuable experience in animal health to Zoetis Board (NYSE:…
Eli Lilly to Present New Data on Imlunestrant, Olomorasib, LY4170156, and Verzenio® at 2025 ASCO Annual Meeting Eli Lilly and Company (NYSE: LLY) announced today that new clinical data from…
New data from SEQUOIA, to be reported in two oral presentations, underscore the benefits of BRUKINSA® as first-line treatment for patients with chronic lymphocytic leukemia (CLL) Promising early phase data show…
The U.S. Bankruptcy Court of New Jersey approved CVS Pharmacy® bids on the prescription files of 625 Rite Aid pharmacies across 15 states in areas that CVS serves, as well 64…
Johnson & Johnson MedTech Launches SOUNDSTAR CRYSTAL™ Ultrasound Catheter in the U.S. to Enhance Cardiac Ablation Procedures May 2025 – Johnson & Johnson MedTech, a global leader in cardiac arrhythmia…
Access to Obesity Medications Shouldn’t Be This Hard Recent changes in insurance coverage have forced thousands of Americans living with obesity into an impossible choice: stop taking a safe, effective…
Eli Lilly’s Kisunla Receives Regulatory Approval in Australia for Early Alzheimer’s Treatment Eli Lilly and Company (NYSE: LLY) announced today that Australia’s Therapeutic Goods Administration (TGA) has granted marketing authorization…
Aetna Better Health® of Illinois Invests $20.4 Million in Value-Based Care to Improve Health Outcomes in Underserved Communities Aetna Better Health® of Illinois, a CVS Health® company (NYSE: CVS), has…